"Interest grows for focal therapy in treating prostate cancer"
September 28, 2021
Urology Times staff
Urology Times Journal, Vol 49 No 10, Volume 49, Issue 10.
V tomto rozhovoru Ardeshir (Art) Rastinehad, DO, pojednává o současném stavu fokální terapie u rakoviny prostaty, roli fúzní biopsie při posunu léčby vpřed a o tom, co by instituce, které chtějí zavést fokální terapii, měly vědět.
Focal therapy confers myriad advantages in prostate cancer treatment but is currently limited to the clinical trial setting. In this interview, Ardeshir (Art) Rastinehad, DO, discusses the current state of focal therapy in prostate cancer, the role of fusion biopsy in pushing the treatment forward, and what institutions looking to implement focal therapy should know. Rastinehad is system director for prostate cancer at Northwell Health and vice chair at the Smith Institute for Urology at Lenox Hill Hospital in New York, New York. Více...